Schwab US Dividend Equity ETF Sees Positive Fund Flows

Schwab US Dividend Equity ETF ( $SCHD ) has fallen by 0.04% in the past week. It has experienced a 5-day net inflow of $29.92 million.
This is due, in part, to market sentiment on some of the ETF’s largest holdings. For example:

• Abbvie has been actively involved in several clinical studies that could significantly impact its stock performance. The company is conducting a Phase 1 study on GUB014295, a potential treatment for weight management, and has completed a Phase 3 study on linaclotide for pediatric constipation. Additionally, AbbVie has concluded a study on risankizumab for psoriasis in Taiwan. These developments, along with a recent analyst upgrade to a Buy rating, suggest potential growth in AbbVie’s portfolio, although insider sentiment remains negative due to recent share sales by executives.
• Chevron is navigating a complex energy market with strategic moves that could bolster its future performance. The company has announced a decrease in Bakken rig activity, affecting its operations in the region. However, Chevron’s recent acquisition of Hess and its record production in the Permian Basin highlight its robust growth strategy. The company’s strong dividend history and potential benefits from a dovish Fed policy further enhance its appeal to investors seeking stable returns.
• Home Depot is facing mixed news with potential impacts on its stock. The company is dealing with immigration enforcement concerns in its parking lots, which has slightly impacted investor sentiment. However, Home Depot’s digital strategy is thriving, with a significant increase in online sales. The company is also benefiting from a favorable interest rate environment, which could boost home improvement spending. Additionally, Home Depot is pursuing a $140 million project in Georgia, supported by tax incentives, and continues to offer attractive dividends, making it a solid long-term investment.